Why AbbVie Stock Flew Higher on Friday
A bellwether stock in the lately rather up-and-down pharmaceutical sector, (NYSE: ABBV) finished the trading week in style. The company's shares closed more than 3% higher in price thanks in no small part to a clutch of post-earnings analyst price-target increases. With that performance, Abbvie crushed the S 500 index, which dived by 1.6% on the day.
As typically happens when a publicly traded company posts better-than-expected quarterly results, those pundits made the positive changes a day after AbbVie published its estimates-besting second-quarter figures.
Image source: Getty Images.
Source Fool.com
AbbVie Inc. Aktie
190,40 €
-0,94 %
Absolute Beliebtheit: AbbVie Inc. hat nur Buy-Einschätzungen.
Ein Kursziel von 209 € für AbbVie Inc. impliziert ein leicht positives Wachstum gegenüber dem aktuellen Kurs von 190.4 €.
